
BOURSSOLE Newsroom
Stay ahead of the market with our curated AI-powered financial news and expert analysis.

Sothema Reports 16% Revenue Surge in H1 2026, Debt Down 18%
Sothema posted a consolidated turnover of MAD 917 million in Q2 2026, a 19 % rise year‑on‑year, and reached MAD 1.795 billion for the first half of the year, up 16 % versus H1 2025. The growth was driven by strong oncology and cardio‑metabolic sales, the contribution of its Senegalese subsidiary and...

Casablanca Stock Exchange’s MASI Index Closes Friday Up 0.96%, Gains 2.5% Over the Week
The Casablanca Stock Exchange ended the week in positive territory. The flagship MASI index finished Friday at 18,474.84 points, up 0.96% on the day a...

Casablanca Stock Exchange's MASI Index Bounces 1.9% After Three Days of Losses
After three consecutive sessions in the red, the Casablanca Stock Exchange found a foothold on Friday. The MASI index recovered gradually throughout t...

Sothema Reports 12% Revenue Rise in Q1 2026, Boosted by New Products and Dialysis Expansion
Sothema announced a solid 12 % increase in consolidated revenue for the first quarter of 2026, reaching MAD 879 million. The growth was driven by stro...

Casablanca Stock Exchange stalls after intraday high, MASI falls 0.35%
The Casablanca Stock Exchange opened strong, pushing the MASI index to a new intraday peak of 18,738.44 points. However, the rally fizzled out and the...

Sothema 2026 Strategy: Scaling Innovation and Global Expansion
As it celebrates its 50th anniversary, Sothema is launching an ambitious strategic roadmap for 2026. The pharmaceutical leader aims to dominate the Mo...
Join 10,000+ Investors
Get the latest market analysis and premium insights delivered to your dashboard.
Create Free Account
Sothema Reports 22% Jump in Net Profit for 2025
Sothema, a leading Moroccan pharmaceutical company, announced a strong 2025 performance with a 22% increase in net profit and a 15% rise in consolidat...

Sothema Slashes Par Value by 80% in 5-for-1 Split, Eyes Broader Liquidity
Sothema unveiled a bold capital re-structuring plan at an extraordinary shareholder meeting held on 25 March 2026 in Bouskoura. The pharmaceutical ...

Sothema Reports 15% Revenue Growth in 2025, Boosted by Soludia Integration
Sothema closed 2025 with a solid 15% increase in consolidated turnover, reaching 3.22 billion MAD. The growth was driven by organic expansion and the ...
